Lumosa Therapeutics Co., Ltd. is a drug development company, which engages in the business of developing drugs for the central nervous system, oncology, and inflammatory diseases. It operates through the following geographical segments: Taiwan, Asia, America, and Europe. The company was founded on November 13, 2000 and is headquartered in Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company